Print Page | Contact Us | Sign In | Join WAPA
SGLT-2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients with Type 2 Diabetes
Tell a Friend About This EventTell a Friend
 

SGLT-2 Inhibition: A Glucuretic Treatment Option for Your Adult Patients with Type 2 Diabetes Dr Victor Howard, MD, FACC Medical Director for Cardiovascular US Medical Affairs at AstraZeneca

9/12/2019
When: September 12, 2019
6:30-8:30 pm
Where: Hagemeister Restaurant
325 N. Washington Street
Green Bay, Wisconsin  54301
United States
Contact: Ellen Yoder
920-410-1600

« Go to Upcoming Event List